Ledger.Open graph →
SEC Form D · filed March 26, 2021

ADIAL PHARMACEUTICALS, INC

Offering
$2.1M
Sold
$291K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CHARLOTTESVILLE, VA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Tony W. Goodman · Charlottesville, VADirectorJames K. Anderson · Charlottesville, VADirectorRobertson H. Gilliland · Charlottesville, VADirectorJames W. Newman, Jr · Charlottesville, VADirectorWilliam B. Stilley, Iii · Charlottesville, VAExec · DirectorKevin W. Schuyler · Charlottesville, VADirectorJoseph M. Truluck · Charlottesville, VAExecW. C. Mccollum · Los Angeles, CAExecPeter Feld · New York, NYDirectorJesse S. Jacobs · Playa Vista, CADirectorGina Mondo · Norwich, CTExec · DirectorKweli Washington · New York, NYDirectorMike Kerns · Playa Vista, CADirectorMichael Korn · New York, NYDirectorThomas Scriven · Golden, CODirectorMatthew Davis · Purcellville, VADirectorFred Ausubel · Allston, MAExecIsaac Stoner · Allston, MAExec · DirectorCory Brown · Nashville, TNDirectorKiran N. Bhatraju · Shepherdstown, WVDirectorElvin Lopez · Whippany, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗